Nordhealth AS(DE:6E5)
€2.26+0.14 (+3.67%)
DE:6E5
Nordhealth AS financials statements
€2.26
At close:+0.14 (+3.67%)
Nordhealth AS (6E5) Ratios
0 Followers
Nordhealth AS Ratios
DE:6E5's free cash flow for Q2 2026 was €-2.50M. For the 2026 fiscal year, DE:6E5's free cash flow was decreased by €-1.02M and operating cash flow was €-1.48M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.21 | 2.99 | 3.14 | 2.79 | 7.77 |
| Quick Ratio | 2.21 | 2.99 | 3.14 | 2.79 | 7.77 |
| Cash Ratio | 1.48 | 0.45 | 0.56 | 0.97 | 2.66 |
| Solvency Ratio | -0.13 | 0.34 | -0.11 | -0.34 | -0.05 |
| Operating Cash Flow Ratio | 0.07 | 0.20 | -0.58 | -0.41 | 0.57 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -261.00 | 222.68 |
| Net Current Asset Value | € 12.07M | € 17.89M | € 19.22M | € 28.29M | € 65.88M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.16 | 1.13 | 1.11 | 1.16 | 1.09 |
| Debt Service Coverage Ratio | -30.77 | 85.89 | -123.13 | -132.02 | -6.88 |
| Interest Coverage Ratio | -283.36 | -208.81 | -1423.38 | -863.47 | -108.71 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 15.23 | -0.97 | 7.67 | 2.86 | 70.96 |
| Profitability Margins | |||||
| Gross Profit Margin | 81.23% | 85.44% | 85.96% | 84.60% | 82.45% |
| EBIT Margin | -24.09% | -14.45% | -29.32% | -45.45% | -22.68% |
| EBITDA Margin | -1.90% | 9.23% | -1.79% | -17.42% | -1.82% |
| Operating Profit Margin | -24.52% | -16.92% | -30.92% | -47.28% | -21.96% |
| Pretax Profit Margin | -24.18% | -14.53% | -29.34% | -45.50% | -22.89% |
| Net Profit Margin | -24.67% | -16.80% | -30.23% | -45.94% | -23.31% |
| Continuous Operations Profit Margin | -24.94% | -16.80% | -30.23% | -45.94% | -23.31% |
| Net Income Per EBT | 102.04% | 115.62% | 103.02% | 100.96% | 101.83% |
| EBT Per EBIT | 98.59% | 85.90% | 94.90% | 96.25% | 104.24% |
| Return on Assets (ROA) | -17.54% | -9.25% | -12.11% | -12.41% | -3.78% |
| Return on Equity (ROE) | -20.38% | -10.42% | -13.45% | -14.46% | -4.13% |
| Return on Capital Employed (ROCE) | -20.25% | -10.46% | -13.74% | -14.84% | -3.87% |
| Return on Invested Capital (ROIC) | -20.25% | -10.46% | -13.74% | -14.84% | -3.98% |
| Return on Tangible Assets | -54.31% | -27.13% | -36.68% | -30.50% | -6.10% |
| Earnings Yield | -5.01% | -2.58% | -6.29% | -8.42% | -1.48% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.43 | 6.01 | 7.52 | 6.81 | 7.81 |
| Payables Turnover | 6.29 | 4.33 | 3.38 | 5.44 | 3.38 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 186.94 | 154.31 | 73.95 | 42.42 | 26.82 |
| Asset Turnover | 0.71 | 0.55 | 0.40 | 0.27 | 0.16 |
| Working Capital Turnover Ratio | 3.37 | 2.44 | 1.54 | 0.65 | 0.59 |
| Cash Conversion Cycle | -14.76 | -23.45 | -59.54 | -13.43 | -61.36 |
| Days of Sales Outstanding | 43.28 | 60.76 | 48.53 | 53.62 | 46.75 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 58.04 | 84.21 | 108.07 | 67.04 | 108.11 |
| Operating Cycle | 43.28 | 60.76 | 48.53 | 53.62 | 46.75 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.01 | 0.02 | -0.07 | -0.08 | 0.07 |
| Free Cash Flow Per Share | -0.05 | -0.04 | -0.14 | -0.17 | 0.03 |
| Dividend Paid and CapEx Coverage Ratio | 0.14 | 0.37 | -0.91 | -0.96 | 0.78 |
| Capital Expenditure Coverage Ratio | 0.14 | 0.37 | -0.91 | -0.96 | 1.65 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | -261.00 | 222.68 |
| Operating Cash Flow to Sales Ratio | 0.01 | 0.04 | -0.14 | -0.21 | 0.27 |
| Free Cash Flow Yield | -1.73% | -1.07% | -6.19% | -7.87% | 0.69% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -19.52 | -38.78 | -15.89 | -11.88 | -67.42 |
| Price-to-Sales (P/S) Ratio | 4.93 | 6.51 | 4.80 | 5.46 | 15.71 |
| Price-to-Book (P/B) Ratio | 4.07 | 4.04 | 2.14 | 1.72 | 2.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -57.88 | -93.81 | -16.16 | -12.71 | 145.65 |
| Price-to-Operating Cash Flow Ratio | 352.13 | 161.02 | -33.87 | -25.96 | 57.30 |
| Price-to-Earnings Growth (PEG) Ratio | -0.30 | 1.27 | 0.72 | -0.06 | 0.28 |
| Enterprise Value Multiple | -244.27 | 69.64 | -260.79 | -28.45 | -793.47 |
| Enterprise Value | 235.72M | 293.47M | 171.86M | 153.90M | 292.79M |
| EV to EBITDA | -244.27 | 69.64 | -260.79 | -28.45 | -793.47 |
| EV to Sales | 4.64 | 6.43 | 4.67 | 4.96 | 14.42 |
| EV to Free Cash Flow | -54.49 | -92.52 | -15.70 | -11.55 | 133.69 |
| EV to Operating Cash Flow | 331.46 | 158.80 | -32.91 | -23.59 | 52.59 |
| Tangible Book Value Per Share | 0.16 | 0.24 | 0.26 | 0.38 | 0.84 |
| Shareholders’ Equity Per Share | 0.77 | 0.93 | 1.03 | 1.23 | 1.43 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.03 | -0.16 | -0.03 | -0.01 | -0.02 |
| Revenue Per Share | 0.63 | 0.58 | 0.46 | 0.39 | 0.25 |
| Net Income Per Share | -0.16 | -0.10 | -0.14 | -0.18 | -0.06 |
| Tax Burden | 1.02 | 1.16 | 1.03 | 1.01 | 1.02 |
| Interest Burden | 1.00 | 1.01 | 1.00 | 1.00 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.07 | 0.07 | 0.04 | 0.06 | 0.17 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.06 | -0.28 | 0.48 | 0.46 | -1.20 |
Currency in EUR
